Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 ENFERMEDAD GRUPO REGISTRY PROYECTOS ENTRAR
 
 
  
Imaging -
--->Novedades
[-]El proyecto
--->Sponsor
--->[+]Comité Ejecutivo
--->[+]Writing Committee Strategic ...
--->[+]Comité Científico y Bioético
--->Coordinador central
--->Coordinadores locales
--->Fellowship Programme
--->[-]Constitución
--->Artículo 1
--->Artículo 2
--->Artículo 3
--->Artículo 4
--->Artículo 5
--->Artículo 6
--->Artículo 7
--->Artículo 8
--->Artículo 9
--->Artículo 10
--->Artículo 11
--->Artículo 12
--->Documentos
--->[+]Elecciones
--->[+]Miembros
[-]Centros
--->[+]Austria
--->[+]Bélgica
--->[+]República Checa
--->[+]Dinamarca
--->[+]Finlandia
--->[+]Francia
--->[+]Alemania
--->[+]Ireland
--->[+]Italia
--->[+]Países Bajos
--->[+]Noruega
--->[+]Polonia
--->[+]Portugal
--->[+]Rusia
--->[+]España
--->[+]Suecia
--->[+]Suiza
--->[+]Reino Unido
--->[+]Fuera de Europa
[-]Grupos de trabajo
--->[-]EH avanzada
--->Acontecimientos
--->[+]Reuniones
--->[+]Fenotipo conductual
--->[+]Modificadores Biológicos
--->[+]Biomarcadores
--->[+]Banco de tejidos y cerebros...
--->[+]Fenotipo cognitivo
--->[+]Modificadores ambientales
--->[-]Evaluación Funcional
--->Acontecimientos
--->[+]Reuniones
--->[+]Test y Consejo genético
--->[+]Genes Modificadores
--->[+]Economia de Salud
--->[+]Pruebas de imagen
--->[+]Huntington Juvenil
--->[+]Fenotipo motor
--->[+]Tratamiento Neuroprotector...
--->[+]Fisioterapia
--->[+]Calidad de vida
--->[+]Cuidados del paciente
--->[+]Tratamiento quirúrgico
--->[+]Tratamiento Sintomático
--->[+]Jóvenes
[-]Eventos
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[-]EHDN 2010
--->Introduction
--->Programme I
--->Programme II
--->Additional Meetings
--->Registration
--->EHA Programme
--->[+]EHA Registration
--->Plenary Dinner
--->Social Programme
--->Important Dates
--->[+]Abstract Submission
--->Reimbursement
--->Hotel Booking
--->[+]Travel and Location
--->[+]About Prague
--->Documents
--->Committees
--->Contact
--->Feedback & Evaluation
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[-]EHDN 2006
--->Introducción
--->Programa
--->Cena de gala
--->Bienvenida a la reunión
--->[+]Sobre el lugar de la reunión...
--->[+]EHDN 2005
--->[+]EHDN 2004
[-]Comunicación
--->¿Cómo contactar?
--->Forums
--->Listas de correos
--->Publicación
--->Ofertas de trabajo
fechadescripcióntamañoautor documento 
04.08.26Alterations in iron content in the brain of Huntington Disease mutation carriers in comparison with healthy control subjects32 kBanonymousapplication/mswordg05-alterations-in-iron-content 
04.08.26Iron defect is implicated in white matter changes in Huntington Disease32 kBanonymousapplication/mswordg06-iron-defect 
04.08.26Reliability of diffusion tensor imaging measures32 kBanonymousapplication/mswordg07-diffusion-tensor-imaging-measures 
04.08.26Brain Structure in Children at Risk for Huntington’s Disease32 kBanonymousapplication/mswordg04-brain-structure-in-children-at-risk 
04.08.26Corpus callosal atrophy in Huntington’s Disease32 kBanonymousapplication/mswordg03-corpus-callosal-atrophy 
04.08.26Evaluation of multi-modal, multi-site imaging measures in Huntington’s Disease: baseline results from the Paddington study32 kBanonymousapplication/mswordg01-imaging-measures-paddington 
04.08.26Brain structure in preclinical Huntington’s disease: a multimethod approach32 kBanonymousapplication/mswordg02-brain-structure-in-preclinical-hd 
04.08.26A multicentre approach for the detection of patterns of impairment in Huntington’s Disease by using diffusion tensor imaging32 kBanonymousapplication/mswordg08-detection-of-patterns-of-impairmen... 
04.08.26Structural connectivity-based topography of the basal ganglia is altered in premanifest and early manifest Huntington’s Disease32 kBanonymousapplication/mswordg09-topography-basal-ganglia 
04.08.26Brain activation and functional connectivity in premanifest Huntington’s disease during states of intrinsic and phasic alertness32 kBanonymousapplication/mswordg14-brain-activation-functional-connec... 
04.08.26Switch of cerebral A1 adenosine receptor radioligand binding during phenoconversion of Huntington disease – a PET study32 kBanonymousapplication/mswordg15-switch-of-cerebral-a1-adenosine-re... 
04.08.26Abnormal responses to visual cortex activation in early stage Huntington Disease patients using 31P-NMR spectroscopy32 kBanonymousapplication/mswordg13-visual-cortex-activation-in-early-... 
04.08.26From premanifest to manifest Huntington’s disease: a two year follow up study with magnetic resonance spectroscopy at 7 Tesla32 kBanonymousapplication/mswordg12-from-premanifest-to-manifest 
04.08.26Correlation between relaxometry and diffusion tensor imaging in the globus pallidus of huntington disease patients32 kBanonymousapplication/mswordg10-correlation-relaxometry-and-diffus... 
04.08.26Tractography of the corpus callosum in Huntington Disease32 kBanonymousapplication/mswordg11-tractography-of-corpus-callosum 
04.08.26Does CAG repeat length modulate rates of brain atrophy in Huntington’s Disease?32 kBanonymousapplication/mswordg0x-cag-repeat-length-brain-atrophy 

Esta carpeta contiene 16 documentos.
about us | privacy statement | disclaimer | terms of use